• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Enfusion Inc.

    4/21/25 4:55:02 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology
    Get the next $ENFN alert in real time by email
    S-8 POS 1 tm2512704d3_s8pos.htm S-8 POS

     

    As filed with the Securities and Exchange Commission on April 21, 2025

     

    Registration No. 333-277853

    Registration No. 333-270451

    Registration No. 333-263969

    Registration No. 333-260398

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM S-8

     

    Post-Effective Amendment No. 1 to Registration Statement No. 333-277853

    Post-Effective Amendment No. 1 to Registration Statement No. 333-270451

    Post-Effective Amendment No. 1 to Registration Statement No. 333-263969

    Post-Effective Amendment No. 1 to Registration Statement No. 333-260398

     

    Under

    The Securities Act of 1933

     

    ENFUSION, INC.

    (Exact name of registrant as specified in its charter)

     

     

    Delaware 87-1268462
    (State or other jurisdiction of (I.R.S. Employer
    incorporation or organization) Identification Number)

     

    c/o Clearwater Analytics Holdings, Inc.

    777 W. Main Street

    Suite 900

    Boise, ID 83702

    (Address of Principal Executive Offices)

    2021 Stock Option and Incentive Plan

    2021 Employee Stock Purchase Plan

    (Full Title of the Plans)

     

     

    Alphonse Valbrune
    Chief Legal Officer
    777 W. Main Street
    Suite 900
    Boise, ID 83702
    (208) 433-1200
    (Name, address, including zip code, and telephone number, including area code, of agent for service)

     

     

    Copies to:

     

    Joshua N. Korff, P.C.

    Ross M. Leff, P.C.

    Christie W.S. Mok

    Kirkland & Ellis LLP

    601 Lexington Avenue

    New York, New York 10022

    (212) 446-4800

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ¨ Accelerated filer x
           
    Non-accelerated filer ¨ Smaller reporting company ¨
           
       

    Emerging growth company

    x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     

     

     

     

    DEREGISTRATION OF SHARES

     

    These Post-Effective Amendments No. 1 to the Registration Statements (“Post-Effective Amendments”) filed by Enfusion, Inc., a Delaware corporation (the “Registrant” or “Enfusion”), remove from registration all securities that remain unsold under the following registration statements on Form S-8 (each, a “Registration Statement,” and collectively, the “Registration Statements”) filed by the Registrant with the Securities and Exchange Commission (the “Commission”):

     

    ·Registration Statement on Form S-8 (Registration No. 333-277853), filed by the Registrant with the Commission on March 12, 2024, pertaining to the registration of the securities described in the Registration Statement;

     

    ·Registration Statement on Form S-8 (Registration No. 333-270451), filed by the Registrant with the Commission on March 10, 2023, pertaining to the registration of the securities described in the Registration Statement;

     

    ·Registration Statement on Form S-8 (Registration No. 333-263969), filed by the Registrant with the Commission on March 30, 2022, pertaining to the registration of the securities described in the Registration Statement; and

     

    ·Registration Statement on Form S-8 (Registration No. 333-260398), filed by the Registrant with the Commission on October 21, 2021, pertaining to the registration of the securities described in the Registration Statement.

     

    On April 21, 2025, pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the “Merger Agreement”), by and among Clearwater Analytics Holdings, Inc., a Delaware corporation (“Clearwater”), Poseidon Acquirer, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Clearwater (“Acquirer”), Poseidon Merger Sub I, Inc., a Delaware corporation and wholly-owned subsidiary of Clearwater (“Merger Sub”), Poseidon Merger Sub II, LLC, a Delaware limited liability company and an indirect subsidiary of Clearwater (“Merger Sub II”), Enfusion, , and Enfusion Ltd. LLC, a Delaware limited liability company and subsidiary of Enfusion (“Enfusion Operating Company”), (i) Merger Sub II merged with and into Enfusion Operating Company (the “LLC Merger”), with Enfusion Operating Company surviving the LLC Merger as a wholly-owned subsidiary of Clearwater; (ii) Merger Sub merged with and into Enfusion (the “Merger”), with Enfusion surviving the Merger as an indirectly wholly-owned subsidiary of Clearwater (the “Surviving Corporation”); and (iii) the Surviving Corporation merged with and into Acquirer (the “Second Merger”, and together with the Merger, the “Corporate Mergers”, and the Corporate Mergers together with the LLC Merger, the “Mergers”), with Acquirer surviving the Second Merger as a wholly-owned subsidiary of Clearwater.

     

    As a result of the completion of the transactions contemplated by the Merger Agreement, including the Mergers, the Registrant has terminated any and all offerings of its securities pursuant to the Registration Statements. In accordance with the undertaking made by the Registrant in the Registration Statements to remove from registration, by means of a post-effective amendment, any of the securities that had been registered for issuance but remain unsold at the termination of the offerings, the Registrant hereby removes from registration any and all of securities of the Registrant registered but unsold under the Registration Statements as of the date hereof. The Registration Statements are hereby amended, as appropriate, to reflect the deregistration of such securities and the Registrant hereby terminates the effectiveness of the Registration Statements.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment to the Registration Statements on Form S-8 described above to be signed on its behalf by the undersigned, thereunto duly authorized, in Boise, Indiana, on April 21, 2025.

     

      ENFUSION, INC.
        
      By:/s/ Alphonse Valbrune
           Name:Alphonse Valbrune
      Title:Secretary

     

    No other person is required to sign this Post-Effective Amendment to the Registration Statements on Form S-8 in reliance upon Rule 478 under the Securities Act of 1933, as amended.

     

     

     

    Get the next $ENFN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ENFN

    DatePrice TargetRatingAnalyst
    5/10/2024$11.00Overweight
    Morgan Stanley
    2/28/2024$9.00 → $8.00Neutral → Sell
    Goldman
    1/30/2024$11.00 → $9.00Neutral → Underweight
    JP Morgan
    11/7/2023$9.00Neutral
    UBS
    4/3/2023$11.00Neutral
    Piper Sandler
    3/15/2023$12.00Neutral
    JP Morgan
    1/4/2023$15.00 → $10.00Neutral → Underperform
    BofA Securities
    1/3/2023$13.00 → $12.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $ENFN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OPENLANE Names Brad Herring Chief Financial Officer

      Bolsters Leadership Bench With More Than 30 Years of Financial Management and Investor Relations Expertise CARMEL, Ind., April 22, 2025 /PRNewswire/ -- OPENLANE, Inc. (NYSE:KAR), a leading operator of digital marketplaces for wholesale used vehicles, announces the company has named Brad Herring as EVP and Chief Financial Officer effective May 27, 2025. Herring will be responsible for leading all financial, reporting and investor-facing functions across OPENLANE, including the company's capital investment strategy. Herring also joins OPENLANE's executive team and will report to CEO Peter Kelly.

      4/22/25 4:15:00 PM ET
      $ENFN
      $FOUR
      $KAR
      Computer Software: Prepackaged Software
      Technology
      Business Services
      Consumer Discretionary
    • Clearwater Analytics Finalizes Acquisition of Enfusion

      Clearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional Investors Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE:ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry's first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management,

      4/21/25 4:15:00 PM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics and Enfusion Announce Preliminary Results of Election by Enfusion Shareholders Regarding Form of Merger Consideration

      Clearwater Analytics (NYSE:CWAN) ("Clearwater") and Enfusion, Inc. (NYSE:ENFN) ("Enfusion") today announced the preliminary results of the elections made by Enfusion shareholders of record regarding the form of merger consideration (the "Merger Consideration") they wish to receive in connection with Clearwater's acquisition of Enfusion (the "Transaction"). As previously disclosed, the deadline to have made such an election was 5:00 p.m. Eastern Time on April 16, 2025 (the "Election Deadline"). The parties expect to close the Transaction on April 21, 2025, subject to the approval of the Transaction by Enfusion shareholders and the satisfaction or waiver of other customary closing conditions

      4/17/25 8:00:00 AM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Morgan Stanley resumed coverage on Enfusion with a new price target

      Morgan Stanley resumed coverage of Enfusion with a rating of Overweight and set a new price target of $11.00

      5/10/24 8:40:24 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Enfusion downgraded by Goldman with a new price target

      Goldman downgraded Enfusion from Neutral to Sell and set a new price target of $8.00 from $9.00 previously

      2/28/24 6:16:11 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Enfusion downgraded by JP Morgan with a new price target

      JP Morgan downgraded Enfusion from Neutral to Underweight and set a new price target of $9.00 from $11.00 previously

      1/30/24 6:55:00 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    SEC Filings

    See more
    • SEC Form 15-12G filed by Enfusion Inc.

      15-12G - Enfusion, Inc. (0001868912) (Filer)

      5/1/25 4:15:29 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • SEC Form EFFECT filed by Enfusion Inc.

      EFFECT - Enfusion, Inc. (0001868912) (Filer)

      4/24/25 12:15:09 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • SEC Form POS AM filed by Enfusion Inc.

      POS AM - Enfusion, Inc. (0001868912) (Filer)

      4/21/25 4:57:41 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Financials

    Live finance-specific insights

    See more
    • Clearwater Analytics Finalizes Acquisition of Enfusion

      Clearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional Investors Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE:ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry's first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management,

      4/21/25 4:15:00 PM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Enfusion Announces Fourth Quarter and Full Year 2024 Results

      Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights: Total revenue was $52.9 million, up 13.9% compared to the same period in the prior year. Gross Profit was $36.5 million with a Gross Profit Margin of 69.0%. Adjusted Gross Profit was $36.9 million with an Adjusted Gross Profit Margin of 69.6%. Net Income was $0.2 million with a Net Income Margin of 0.3%. Adjusted EBITDA was $12.3 million, up 25.3% compared to the same period in the prior year. Operating Cash Fl

      3/3/25 4:05:00 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities

      Investor Conference Call Scheduled for Today at 8:30 a.m. ET Clearwater Analytics (NYSE:CWAN) ("Clearwater") and Enfusion, Inc. (NYSE:ENFN) ("Enfusion") today announced their entry into a definitive merger agreement for Clearwater to acquire Enfusion, a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund industry. The purchase price is $11.25 per share, delivered in an approximately equal mix of cash and stock. Additionally, Clearwater will pay $30 million to terminate Enfusion's tax receivable agreement (TRA). This equates to a purchase price of approximately $1.5 billion. This press release features multimedia. View the full release here: https

      1/13/25 6:30:00 AM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Leadership Updates

    Live Leadership Updates

    See more
    • FTV Capital Named to Inc.'s Founder-Friendly Investors List for Fourth Consecutive Year

      FTV Capital, a leading sector-focused growth equity investment firm, today announced its inclusion for the fourth consecutive year on Inc.'s annual Founder-Friendly Investors list, which honors the private equity, venture capital firms and lenders with a track record of backing founder-led companies. This year's list recognizes 269 firms that believe in backing founder-led businesses and helping them thrive, demonstrated by their successful track records of collaboration and remaining actively involved with their portfolio companies to drive growth. "We are honored to be recognized again by Inc. for our ongoing commitment to serving as a collaborative, strategic partner to founders and ent

      10/29/24 7:00:00 AM ET
      $ENFN
      $GLOB
      Computer Software: Prepackaged Software
      Technology
      EDP Services
    • Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation

      Appointments of Arman Artuc to Head of Engineering, and Jesper Cordes to Head of Client Services Americas, Will Further Elevate Enfusion's Operations as an Investment Technology Industry Leader Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, announced today the appointments of Arman Artuc to Head of Engineering and Jesper Cordes to Head of Client Services Americas. These additions to the leadership team reinforce the company's position as a global leader in investment technology and services, which enables Enfusion to continue to attract top-performing industry experts and innovators to its ranks. Enfusion is s

      10/10/24 9:00:00 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • ZEMA Global Data Corporation to Acquire Morningstar Commodity Data

      Transformative acquisition will position ZEMA as global leader in offering high-quality enterprise data management and analytics for the energy and commodities industry ZEMA Global Data Corporation (formerly ZE PowerGroup), a leading provider of enterprise data management and analytics for the commodity and energy sectors, today announced its plans to acquire Morningstar Commodity Data, a provider of commodities and energy data and insights. The transaction is expected to close later this month. The business will serve a diverse portfolio of over 200 enterprises with an expanded product offering and broader geographic operations to support customers around the world. The announcement come

      9/23/24 8:00:00 AM ET
      $ENFN
      $GLOB
      Computer Software: Prepackaged Software
      Technology
      EDP Services

    $ENFN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

      SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

      10/29/24 7:13:25 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

      SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

      10/25/24 4:30:55 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

      SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

      9/6/24 3:32:03 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Iconiq Strategic Partners V, L.P. disposed of 9,009,594 shares (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/23/25 4:30:12 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Director Luo Roy returned 9,009,594 shares to the company (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/23/25 4:30:09 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Chief Operating Officer Pawar Neal returned 1,217,308 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/21/25 5:11:16 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology